SCHEMBL21164617

SCHEMBL21164617

CCCCC(C)(CCCC)NC(=O)CNC(C)C

nearest known ligand 0.37

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
FAAH O00519 1/20 0.37
MAPK1 P28482 1/20 0.37
DPP4 P27487 1/20 0.32
EPHX1 P07099 2/20 0.32
BCHE P06276 1/20 0.31
CTSK P43235 1/20 0.31
BIRC2 Q13490 1/20 0.31
HRH3 Q9Y5N1 1/20 0.30
LMNA P02545 1/20 0.30
POLB P06746 1/20 0.30
GRK2 P25098 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24926543 0.95 MEN1 (0.41) MEN1KMT2AALDH1A1FAAHMAPK1
SCHEMBL21164763 0.86 ALDH1A1 (0.49) MEN1KMT2AALDH1A1FAAHMAPK1
SCHEMBL24927078 0.83 MEN1 (0.36) MEN1KMT2AALDH1A1FAAHMAPK1
SCHEMBL24926995 0.83 MEN1 (0.36) MEN1KMT2AALDH1A1FAAHMAPK1
SCHEMBL19728355 0.78 MEN1 (0.40) MEN1KMT2AALDH1A1FAAHMAPK1
SCHEMBL18867143 0.76 ADH1B (0.39) ALDH1A1EPHX1HRH3LMNA
SCHEMBL21164616 0.75 MAPT (0.40) ALDH1A1DPP4LMNAPOLB
SCHEMBL19069143 0.73 ALDH1A1 (0.39) ALDH1A1EPHX1HRH3LMNA
SCHEMBL26329684 0.73 ALDH1A1 (0.32) ALDH1A1DPP4
SCHEMBL18948738 0.72 ADH1B (0.43) MEN1KMT2AALDH1A1FAAHEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage WASE, NISHIKANT 2020-03-05 US disclosed
US-10351883-B2 Compounds for increasing lipid synthesis and storage NUTECH VENTURES (US) 2019-07-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351883-B2 Compounds for increasing lipid synthesis and storage FASN, LIPC, SREBF2 MEN1 2824/4885KMT2A 2512/4885ALDH1A1 1121/4885
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 MEN1 2824/4885KMT2A 2512/4885ALDH1A1 1121/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.